Literature DB >> 11571579

Immune-mediated destruction of transfected myocytes following DNA vaccination occurs via multiple mechanisms.

P J Payette1, R D Weeratna, M J McCluskie, H L Davis.   

Abstract

The delivery of antigenic proteins in the context of a DNA vaccine leads to the intracellular synthesis of antigen and the induction of both humoral and cellular immune responses. Subsequent to immune activation, any transfected cell expressing the immunogenic protein should, by the rules of immunology, become a legitimate target for removal by immune-mediated mechanisms. Herein, we have used an indirect assay of myocyte integrity following intra-muscular (i.m.) delivery of a DNA vaccine, in mice with various immune deficiencies, to determine which immunological mechanisms may be involved in destruction of antigen-expressing cells. We demonstrate that destruction of antigen- expressing myocytes following i.m. injection of a DNA vaccine is dependent on major histocompatibility complex (MHC) class II restricted CD4+ T cell activation, but is not mediated solely by MHC I-restricted or perforin-mediated lysis and appears to have a component that is antibody-mediated. Although we studied myocytes, the results likely represent what happens to any transfected cell expressing a foreign antigen. This study underscores the ability of DNA vaccines at inducing antigen-specific immune responses that include a number of effector mechanisms. From the perspective of gene therapy, this study highlights the significance of immune activation when considering strategies where maintenance of therapeutic gene expression is desired.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11571579     DOI: 10.1038/sj.gt.3301534

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  6 in total

1.  Plasmid DNA vaccine-elicited cellular immune responses limit in vivo vaccine antigen expression through Fas-mediated apoptosis.

Authors:  John R Greenland; Ralf Geiben; Sharmistha Ghosh; William A Pastor; Norman L Letvin
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422

2.  Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.

Authors:  Man Ki Song; Christofer J Vindurampulle; Alejandra V E Capozzo; Jeffrey Ulmer; John M Polo; Marcela F Pasetti; Eileen M Barry; Myron M Levine
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Optimization of skin electroporation in mice to increase tolerability of DNA vaccine delivery to patients.

Authors:  Anna-Karin Roos; Fredrik Eriksson; Derin C Walters; Pavel Pisa; Alan D King
Journal:  Mol Ther       Date:  2009-06-16       Impact factor: 11.454

4.  The injection of plasmid DNA in mouse muscle results in lifelong persistence of DNA, gene expression, and humoral response.

Authors:  Gemma Armengol; Lina Maria Ruiz; Sergio Orduz
Journal:  Mol Biotechnol       Date:  2004-06       Impact factor: 2.695

5.  Effects of APC De-targeting and GAr modification on the duration of luciferase expression from plasmid DNA delivered to skeletal muscle.

Authors:  Maria C Subang; Rewas Fatah; Ying Wu; Drew Hannaman; Jason Rice; Claire F Evans; Yuti Chernajovsky; David Gould
Journal:  Curr Gene Ther       Date:  2015       Impact factor: 4.391

6.  Optical imaging of luminescence for in vivo quantification of gene electrotransfer in mouse muscle and knee.

Authors:  C Bloquel; C Trollet; E Pradines; J Seguin; D Scherman; M F Bureau
Journal:  BMC Biotechnol       Date:  2006-03-08       Impact factor: 2.563

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.